top of page

Chief Operating Officer (COO)

Ms. May Tsai

Chief Operating Officer (COO) of

YD Biopharma

May Tsai is an experienced business executive with over two decades of expertise in supply chain management, procurement, project management, and risk management. As Chief Operating Officer (COO) at YD Biopharma, she brings extensive knowledge in driving business strategies, promoting operational excellence, and strengthening stakeholder engagement to support the company’s growth and global expansion initiatives.

“At YD Biopharma, we are committed to advancing the future of healthcare through innovation, operational efficiency, and strategic business development. Together, we aim to deliver impactful solutions that contribute to improving patient care and shaping the future of the industry.”

EVN08861.jpg

Academic Excellence

Master of Business Administration, University of North Carolina, Charlotte (2008–2009)

Diploma in Business Mathematics, SooChow University (1989–1994)

畢業

Professional Achievements

Successfully leading procurement and supply chain teams to achieve cost savings, operational KPIs, and business goals.

Leading office relocation and renovation projects, enhancing workspaces and driving operational excellence.

Pioneering the implementation of end-to-end processes and SAP ERP systems to streamline procurement and improve forecasting accuracy.

Building strong relationships with key stakeholders, resulting in increased business satisfaction and improved project outcomes.

Image by Scott Graham

Professional Experience

Country Head of Procurement Taiwan & Hong Kong, Novartis Taiwan (2018–2023)

Head of Procurement TW & Asia Cluster, Novartis Taiwan (2014–2017)

Sourcing Head, Novartis Taiwan (2013–2014)

Logistics Manager, Novartis Taiwan (2006–2010)

品牌戰略

Vision and Leadership

May Tsai’s leadership blends her strong background in procurement and project management with her ability to drive strategic initiatives and operational success. She is committed to expanding YD Biopharma’s presence globally, ensuring the company remains at the forefront of innovation and business excellence.

商務會議
bottom of page